The antitumour activity of cisplatin-based chemotherapy for head and neck cancer is similar between young and elderly patients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1427, 2004-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins

By Khrunin Andrey   Ivanova Feodosia   Moisseev Alexey   Khokhrin Denis   Sleptsova Yuliya   Gorbunova Vera   Limborska Svetlana  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 171-178

Future Medicine

Access to resources Recommend Favorite

Management of Head and Neck Cancer in Elderly Patients

By Lalami Yassine  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 571-583

Adis International

Access to resources Recommend Favorite

Chemotherapy in head and neck cancer

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cisplatin, fluorouracil, docetaxel in head and neck cancer

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Combination therapy with erlotinib and cisplatin is effective in patients with recurrent or metastatic squamous cell cancer of the head and neck

By  

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite